UTHR
United Therapeutics Corporation
NASDAQ · USHealthcareBiotechnology
$529.34-1.18%
Price as of Jul 20, 2026
UTHR valuation
United Therapeutics Corporation valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- 35.34x
- P/E 2026E
- 17.82x
- P/E 2027E
- 16.42x
- P/E 2028E
- 13.79x
- P/S forward
- 6.62x
Trailing multiples
- P/E TTM
- 18.08x
- PEG TTM
- 0.87x
- Price / book
- 3.81x
- Price / sales
- 7.09x
- Price / cash flow
- 14.37x
Enterprise value
- Enterprise value
- $20.3B
- EV / sales
- 6.41x
- EV / EBITDA
- 11.86x
- EV / EBIT
- 14.14x
- Market cap
- $22.5B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.